Cargando…

Personalized medicine using DNA biomarkers: a review

Biomarkers are of increasing importance for personalized medicine, with applications including diagnosis, prognosis, and selection of targeted therapies. Their use is extremely diverse, ranging from pharmacodynamics to treatment monitoring. Following a concise review of terminology, we provide examp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziegler, Andreas, Koch, Armin, Krockenberger, Katja, Großhennig, Anika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432208/ https://www.ncbi.nlm.nih.gov/pubmed/22752797 http://dx.doi.org/10.1007/s00439-012-1188-9

Ejemplares similares

COVID-19 hits a trial: Arguments against hastily deviating from the plan
por: Großhennig, Anika, et al.
Publicado: (2020)

No solution yet for combining two independent studies in the presence of heterogeneity
por: Gonnermann, Andrea, et al.
Publicado: (2015)

Critical appraisal of arguments for the delayed-start design proposed as alternative to the parallel-group randomized clinical trial design in the field of rare disease
por: Spineli, Loukia M., et al.
Publicado: (2017)

A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial
por: Ahlenstiel-Grunow, Thurid, et al.
Publicado: (2014)

Diagnostic value of carotid intima-media thickness and clinical risk scores in determining etiology of ischemic stroke
por: Sievering, Esther MW, et al.
Publicado: (2023)

Personalized Medicine Using Neuroimmunological Biomarkers in Depressive Disorders
por: Chi, Suhyuk, et al.
Publicado: (2021)

Effect of Acute Ozone Induced Airway Inflammation on Human Sympathetic Nerve Traffic: A Randomized, Placebo Controlled, Crossover Study
por: Tank, Jens, et al.
Publicado: (2011)

Implications for blinding in clinical trials with THC-containing cannabinoids based on the CANNA-TICS trial
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2022)

Colorectal Cancer Biomarkers in the Era of Personalized Medicine
por: Patel, Jai N., et al.
Publicado: (2019)

A novel integrated care concept (NICC) versus standard care in the treatment of chronic cardiovascular diseases: protocol for the randomized controlled trial CardioCare MV
por: Schmidt, Christian, et al.
Publicado: (2018)

Personalized medicine in rheumatology
por: Kłak, Anna, et al.
Publicado: (2016)

Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms, MicroRNAs and Personalized Medicine for Patients with Peripheral Arterial Disease
por: Poredoš, Pavel, et al.
Publicado: (2022)

Personalized medicine in diabetes: the role of ‘omics’ and biomarkers
por: Pearson, E. R.
Publicado: (2016)

Genetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine
por: Aronica, Lucia, et al.
Publicado: (2022)

Manual therapy applied by general practitioners for nonspecific low back pain: results of the ManRück pilot-study
por: Lingner, Heidrun, et al.
Publicado: (2018)

Germline genetic biomarkers to stratify patients for personalized radiation treatment
por: Deichaite, Ida, et al.
Publicado: (2022)

Biomarkers in solid organ transplantation: establishing personalized transplantation medicine
por: Roedder, Silke, et al.
Publicado: (2011)

Contribution of biomarkers to personalized medicine
por: Hayes, Daniel F
Publicado: (2010)

The TRANSNephro-study examining a new transition model for post-kidney transplant adolescents and an analysis of the present health care: study protocol for a randomized controlled trial
por: Kreuzer, Martin, et al.
Publicado: (2014)

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance
por: Gonzalez de Castro, D, et al.
Publicado: (2013)

Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization
por: Ong, Frank S., et al.
Publicado: (2013)

Discovery of biomarkers in rare diseases: innovative approaches by predictive and personalized medicine
por: Gülbakan, Basri, et al.
Publicado: (2016)

Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone Metastases
por: Wood, Steven L., et al.
Publicado: (2020)

Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer
por: Koulis, Christine, et al.
Publicado: (2020)

Biomarker testing of cytology specimens in personalized medicine for lung cancer patients
por: Kim, Hyojin, et al.
Publicado: (2022)

Genomic Biomarkers for Personalized Medicine: Development and Validation in Clinical Studies
por: Matsui, Shigeyuki
Publicado: (2013)

Personalized Medicine in Cardiovascular Diseases
por: Lee, Moo-Sik, et al.
Publicado: (2012)

Personalized medicine: new genomics, old lessons
por: Offit, Kenneth
Publicado: (2011)

Statistical Analysis of Biomarkers for Personalized Medicine
por: Eguchi, Shinto, et al.
Publicado: (2013)

Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine
por: Kamel, Hala Fawzy Mohamed, et al.
Publicado: (2017)

Comparison of SCAphoid fracture osteosynthesis by MAGnesium-based headless Herbert screws with titanium Herbert screws: protocol for the randomized controlled SCAMAG clinical trial
por: Könneker, Sören, et al.
Publicado: (2019)

Splice variants of the endonucleases XPF and XPG contain residual DNA repair capabilities and could be a valuable tool for personalized medicine
por: Lehmann, Janin, et al.
Publicado: (2017)

Statistical analysis plan for the randomized controlled trial CardioCare MV investigating a novel integrated care concept (NICC) for patients suffering from chronic cardiovascular disease
por: Ziegler, Andreas, et al.
Publicado: (2020)

Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial
por: Bavendiek, Udo, et al.
Publicado: (2023)

Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine
por: Hu, Linping, et al.
Publicado: (2014)

Contribution of Multiplex Immunoassays to Rheumatoid Arthritis Management: From Biomarker Discovery to Personalized Medicine
por: Laborde, Carlos M., et al.
Publicado: (2020)

Analyzing Precision Medicine Utilization with Real-World Data: A Scoping Review
por: Douglas, Michael P., et al.
Publicado: (2022)

Emerging Biomarkers in the Era of Personalized Cancer Medicine
por: Ricciuti, Biagio, et al.
Publicado: (2019)

Colon Cancer Biomarkers: Implications for Personalized Medicine
por: Pritzker, Kenneth P.H.
Publicado: (2020)

Biomarker and Companion Diagnostics—A Review of Medicinal Products Approved by the European Medicines Agency
por: Orellana García, Laura Patricia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2obtpg178c2out57c8s1b168d0